A national registry for healthy volunteers in phase 1 clinical trials

JAMA

Volumn 305, Issue 12, 2011, Pages 1236-1237

  Resnik, David B ^a   Koski, Greg ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RESEARCH; DRUG SAFETY; EPIDEMIOLOGICAL DATA; FACTUAL DATABASE; FINANCIAL MANAGEMENT; HUMAN; INFORMATION SYSTEM; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REGISTER; RESEARCH ETHICS; RISK REDUCTION;

EID: 79952855322     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.354     Document Type: Note

References (10)

1. Abadie R. The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects. Durham, NC: Duke University Press; 2010.
2. Motluk A. Perils of the professional lab rat. New Sci. 2009;(2718):40-43.
3. Shamoo AE, Resnik DB. Strategies to minimize risks and exploitation in phase one trials on healthy subjects. Am J Bioeth. 2006;6(3):W1-W13. (Pubitemid 43879581)
4. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701-2711.
5. Jaillon P. Healthy volunteers data bank: where and how? Fundam Clin Pharmacol. 1990;4(suppl 2):177s-181s.
6. What is TOPS? The Over Volunteering Prevention System (TOPS) Web site. http://www.tops.org.uk/site/cms/contentChapterView.asp?chapter=1. Accessed January 18, 2011.
7. Zanini GM, Marone C. A new job: research volunteer? Swiss Med Wkly. 2005; 135(21-22):315-317.
8. Boyar D, Goldfarb NM. Preventing overlapping enrollment in clinical studies. J Clin Res Best Pract. 2010;6(4). http://firstclinical.com/journal/ 2010/1004-ClinRSVP.pdf. Accessed January 18, 2011.
9. Code of Federal Regulations Title 21 Part 11: electronic records, electronic signatures. US Food and Drug Administration Web site. http://www.accessdata .fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart= 11. Accessed February 24, 2011.
10. Almeida L, Azevedo B, Nunes T, Vaz-da-Silva M, Soares-da-Silva P. Why healthy subjects volunteer for phase I studies and how they perceive their participation? Eur J Clin Pharmacol. 2007;63(11):1085-1094.